| # | Drug | Count |
|---|---|---|
| 0 | EMICIZUMAB | 890 |
| 1 | RIVAROXABAN | 603 |
| 2 | ASPIRIN | 261 |
| 3 | ASPIRIN 325 MG | 248 |
| 4 | ASPIRIN 81 MG | 248 |
| 5 | FUROSEMIDE | 205 |
| 6 | WARFARIN | 201 |
| 7 | ACETAMINOPHEN | 164 |
| 8 | CLOPIDOGREL | 158 |
| 9 | SODIUM CHLORIDE | 155 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONCIZUMAB | 11 | 0.2444 |
| 1 | MARSTACIMAB-HNCQ | 21 | 0.2039 |
| 2 | COAGULATION FACTOR IX RECOMBINANT, GLYCOPEGYLATED | 9 | 0.1324 |
| 3 | CHERRY PLUM, FERR PHOS, HORNBEAM, KALI SULPH, NAT MUR, OAK, OLIVE, THYMUS (CALF), ZINC MUR | 1 | 0.0909 |
| 4 | FITUSIRAN | 5 | 0.0893 |
| 5 | EMICIZUMAB | 890 | 0.0691 |
| 6 | ANTI-INHIBITOR COAGULANT COMPLEX | 65 | 0.0589 |
| 7 | AMINOCAPROIC ACID | 36 | 0.0449 |
| 8 | ETRANACOGENE DEZAPARVOVEC | 1 | 0.0154 |
| 9 | COLESEVELAM HCL | 1 | 0.0135 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 663 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 507 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 268 |
| 3 | Loop Diuretic [EPC] | 251 |
| 4 | Corticosteroid [EPC] | 243 |
| 5 | Osmotic Laxative [EPC] | 215 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 187 |
| 7 | Proton Pump Inhibitor [EPC] | 155 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 121 |
| 9 | Vitamin C [EPC] | 120 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue Factor Pathway Inhibitor Antagonist [EPC] | 11 | 0.2444 |
| 1 | Antithrombin-directed RNA Interaction [EPC] | 5 | 0.0893 |
| 2 | Small Interfering RNA [EPC] | 5 | 0.0312 |
| 3 | Antifibrinolytic Agent [EPC] | 79 | 0.0080 |
| 4 | Factor Xa Inhibitor [EPC] | 663 | 0.0024 |
| 5 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 6 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 8 | 0.0011 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 121 | 0.0010 |
| 9 | Cardiac Glycoside [EPC] | 63 | 0.0009 |